Reactive Oxygen Species: Drivers of Physiological and Pathological Processes
J. Checa,
J. Aran
|
8 |
2020 |
8
2020
|
Mechanisms of NF-κB p65 and strategies for therapeutic manipulation
Sivagami Giridharan,
M. Srinivasan
|
8 |
2018 |
8
2018
|
Inflammatory mechanisms in the lung
8 auth.
B. Moldoveanu,
P. Otmishi,
P. Jani,
J. Walker,
X. Sarmiento,
J. Guardiola,
...
M. Saad,
Jerry Yu
|
8 |
2008 |
8
2008
|
Inflammatory bowel disease: clinical aspects and treatments
M. Fakhoury,
R. Negrulj,
A. Mooranian,
H. Al‐Salami
|
8 |
2014 |
8
2014
|
Vitamin D and inflammatory diseases
Kai Yin,
D. Agrawal
|
8 |
2014 |
8
2014
|
A review of vagus nerve stimulation as a therapeutic intervention
Rhaya L. Johnson,
Christopher G. Wilson
|
8 |
2018 |
8
2018
|
Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives
Ema Ozaki,
M. Campbell,
Sarah L. Doyle
|
8 |
2015 |
8
2015
|
The role of inflammation in irritable bowel syndrome (IBS)
Q. Ng,
A. Soh,
Wayren Loke,
Donovan Yutong Lim,
W. Yeo
|
7 |
2018 |
7
2018
|
The role of the NLRP3 inflammasome in gout
S. Kingsbury,
P. Conaghan,
M. McDermott
|
7 |
2011 |
7
2011
|
Spotlight on the NLRP3 inflammasome pathway
Marine Groslambert,
B. Py
|
7 |
2018 |
7
2018
|
Targeting neuroinflammation in Alzheimer’s disease
M. R. Bronzuoli,
A. Iacomino,
L. Steardo,
C. Scuderi
|
7 |
2016 |
7
2016
|
Lipoxins: nature’s way to resolve inflammation
J. Chandrasekharan,
N. Sharma-Walia
|
7 |
2015 |
7
2015
|
The microbiota in inflammatory bowel disease: current and therapeutic insights
Erin R. Lane,
T. Zisman,
D. Suskind
|
7 |
2017 |
7
2017
|
Magnesium deficiency and increased inflammation: current perspectives
F. Nielsen
|
7 |
2018 |
7
2018
|
